* Egalet receives fda approval for arymo er (morphine
sulfate) c-ii, an extended-release morphine product formulated
with abuse-deterrent properties for treatment of chronic pain
The post BRIEF-Egalet receives FDA approval for Arymo ER appeared first on NASDAQ.